Measles-containing-vaccine first-dose (MCV1) immunization coverage in Serbia
Serbia: Measles-containing-vaccine first-dose (MCV1) immunization coverage was 73.0% in 2025. ▼ Falling
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Serbia, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Serbia recorded 73.0% for measles-containing-vaccine first-dose (mcv1) immunization coverage in 2025. That is the lowest value across all 26 years on record.
Compared with earlier readings it is down 13.1% on the previous year and down 16.1% over ten years.
Over the whole period, measles-containing-vaccine first-dose (mcv1) immunization coverage in Serbia peaked at 96.0% in 2005 and was at its lowest, 73.0%, in 2025.
That places Serbia 156th out of 194 countries with data for 2025, putting it in the bottom quarter.
The long-run direction has been consistently falling across the 26 years of available data.
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Serbia, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 89.0% | — |
| 2001 | 90.0% | +1.1% |
| 2002 | 92.0% | +2.2% |
| 2003 | 87.0% | -5.4% |
| 2004 | 89.0% | +2.3% |
| 2005 | 96.0% | +7.9% |
| 2006 | 88.0% | -8.3% |
| 2007 | 95.0% | +8.0% |
| 2008 | 92.0% | -3.2% |
| 2009 | 95.0% | +3.3% |
| 2010 | 95.0% | +0.0% |
| 2011 | 93.0% | -2.1% |
| 2012 | 87.0% | -6.5% |
| 2013 | 92.0% | +5.7% |
| 2014 | 86.0% | -6.5% |
| 2015 | 87.0% | +1.2% |
| 2016 | 82.0% | -5.7% |
| 2017 | 86.0% | +4.9% |
| 2018 | 93.0% | +8.1% |
| 2019 | 87.0% | -6.5% |
| 2020 | 78.0% | -10.3% |
| 2021 | 75.0% | -3.8% |
| 2022 | 81.0% | +8.0% |
| 2023 | 84.0% | +3.7% |
| 2024 | 84.0% | +0.0% |
| 2025 | 73.0% | -13.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 91.3% | 87.0% | 96.0% | 10 |
| 2010s | 88.8% | 82.0% | 95.0% | 10 |
| 2020s | 79.2% | 73.0% | 84.0% | 6 |
Countries ranked near Serbia
More health data for Serbia
- Un projection of annual infant deaths, annual growth rate -5.26 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3584 % change on previous year (2090)
- Heat deaths vs projected death rates 1,502 (2090)
- Un projection of annual infant deaths 18 (2100)
- Population ages 0-14, female, annual growth rate -1.12 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.0704 units per person (2025)
- Population ages 0-14, male, annual growth rate -0.7512 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.0721 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine first-dose (mcv1) immunization coverage in Serbia?
- Measles-containing-vaccine first-dose (mcv1) immunization coverage in Serbia was 73.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Serbia?
- The highest recorded value was 96.0% in 2005.
- What is the lowest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Serbia?
- The lowest recorded value was 73.0% in 2025.
- How does Serbia rank for measles-containing-vaccine first-dose (mcv1) immunization coverage?
- Serbia ranks 156th out of 194 countries with data for 2025.
- Is measles-containing-vaccine first-dose (mcv1) immunization coverage rising or falling in Serbia?
- Over the last ten years it is down 16.1%. The long-run trend across the full record is falling.
- Where does this Serbia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).